This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Gastroparesis is a medical condition in which the stomach muscles become weak and fail to contract normally, causing food to remain in the stomach longer than it should. This can lead to symptoms such as nausea, vomiting, abdominal pain, bloating, early satiety, and weight loss. Gastroparesis is sometimes referred to as delayed gastric emptying. The exact cause of gastroparesis is often unknown, but can be a result of a number of conditions, including diabetes, abdominal surgery, and certain medications. People with diabetes are particularly at risk for developing gastroparesis due to damage to the vagus nerve, which controls the muscles of the stomach. People with diabetes may also experience a decrease in stomach acid production, which can further impair the emptying process. Treatment for gastroparesis is focused on symptom relief and improving the ability of the stomach to empty. This may include dietary changes such as eating smaller meals more often, avoiding high fiber or fatty foods, and avoiding lying down after eating. Medications such as prokinetics, which increase stomach contractions, may also be prescribed. In some cases, surgery or a feeding tube may be necessary. It is important to see a doctor if you are experiencing prolonged nausea, vomiting, abdominal pain, or other symptoms associated with gastroparesis. Early diagnosis and treatment can help to manage symptoms and prevent complications.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States